Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Impact Biomedical Inc IBO

Healthcare
Impact Biomedical Inc. is a human healthcare company and is a wholly owned subsidiary of DSS, Inc. The Company, through the utilization of its intellectual property rights, or through investment in, or through acquisition of companies in the bio health and biomedical fields, focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and... see more

Recent & Breaking News (NYSEAM:IBO)

    Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

    GlobeNewswire 5 days ago

    Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker(TM) Technology Targeting Inflammatory Disease

    GlobeNewswire October 15, 2024

    Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

    GlobeNewswire October 7, 2024

    Impact BioMedical Inc. (NYSE: IBO) Announces 3F(TM) US Patent Issue

    GlobeNewswire September 26, 2024

    Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth

    GlobeNewswire September 23, 2024

    Impact BioMedical Inc. Announces the Closing of its Initial Public Offering

    GlobeNewswire September 17, 2024

    DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

    GlobeNewswire September 16, 2024

    Impact BioMedical Inc. Announces Pricing of Initial Public Offering

    GlobeNewswire September 16, 2024